Adaptive Biotechnologies Corp

Maps immune genetics for blood cancer diagnostics and drug discovery partnerships.

ADPT | NDAQ

Overview

Corporate Details

ISIN(s):: US00650F1093
LEI:
Country:: United States of America
Address:: 1165 EASTLAKE AVE E, 98109 SEATTLE
Website:: https://www.adaptivebiotech.com
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Adaptive Biotechnologies is a commercial-stage biotechnology company pioneering the field of immune medicine. The company's proprietary Immune Medicine Platform maps the genetics of the adaptive immune system by sequencing T-cell and B-cell receptors at scale. This technology enables two primary application areas: clinical diagnostics and drug discovery. Its key diagnostic product is a highly sensitive, next-generation sequencing (NGS)-based assay for the assessment of Minimal Residual Disease (MRD) in blood cancers, used in both clinical practice and drug trials. Additionally, Adaptive partners with pharmaceutical companies, providing rich immune receptor data and services to inform clinical trials and support the development of new therapeutics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Adaptive Biotechnologies Corp filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Adaptive Biotechnologies Corp

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Adaptive Biotechnologies Corp via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
GRAIL, Inc. A biotech company that detects multiple cancers early with a single blood test.	United States of America	GRAL
Greatland Resources Limited A gold and copper producer operating and developing mines in Western Australia's Paterson region.	Australia	GGP
Groupe CRIT International provider of human resources, airport assistance, and industrial services.	France	CEN
Gubra A/S CRO & biotech accelerating peptide drug discovery for metabolic and fibrotic diseases.	Denmark	GUBRA
HACKETT GROUP, INC. IP-based strategic advisory on Gen AI and digital transformation for global enterprises.	United States of America	HCKT
HALOZYME THERAPEUTICS, INC. Licenses a drug delivery platform to biopharma, converting IV drugs to subcutaneous injections.	United States of America	HALO
HANATOUR JAPAN CO.,LTD. B2C/B2B travel firm providing packages, MICE, and inbound services, with a focus on Korea.	Japan	6561
HANATOUR SERVICE INC. South Korea's top travel firm offering package tours and custom trips for B2C & B2B clients.	South Korea	039130
Hanmi Science Co.,Ltd A holding company managing R&D-focused pharmaceutical, API, and medical device firms.	South Korea	008930
Haoxi Health Technology Ltd An online marketing solutions provider for the healthcare industry, focusing on video and news feed ads.	United States of America	HAO